Table 2 The recurrence sites of cHCC, HCC, and iCCA. The values in parentheses are the percentages of all cHCC, HCC, and iCCA cases. In patients with multiple organ recurrence, each organ was counted
From: Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
| Â | cHCC-CCA | HCC | iCCA |
|---|---|---|---|
Liver | 11 (57.9%) | 412 (55.5%) | 48 (39.7%) |
Lung | 3 (15.8%) | 83 (11.2%) | 19 (15.7%) |
Lymph node | 3 (15.8%) | 40 (5.4%) | 21 (17.4%) |
Biliary tract | 1 (5.2%) | 0 | 0 |
Adrenal gland | 1 (5.2%) | 14 (18.9%) | 2 (1.7%) |
Bone | 1 (5.2%) | 39 (5.3%) | 16 (13.2%) |
Peritoneum | 0 | 10 (1.3%) | 11 (9.1%) |
Brain | 0 | 11 (1.5%) | 1 (0.8%) |